K233313 is an FDA 510(k) clearance for the Keikku Electronic stethoscope. This device is classified as a Stethoscope, Electronic (Class II - Special Controls, product code DQD).
Submitted by Lapsi Health Holding B.V. (Amsterdam, NL). The FDA issued a Cleared decision on April 10, 2024, 194 days after receiving the submission on September 29, 2023.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1875.
| 510(k) Number | K233313 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 29, 2023 |
| Decision Date | April 10, 2024 |
| Days to Decision | 194 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQD - Stethoscope, Electronic |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1875 |